Another remarkable finding is that the reduction in expression of insulin-like growth factor-1 (IGF-1 and 2) in vitro and in vivo has very important therapeutic value, as it has been reported that the IGF-1-stimulated signal transduction pathway stimulates breast cancer cell proliferation, survival, and metastasis. The gene discussed is IGF1; the disease is breast carcinoma.